[DOI] [PubMed] [Google Scholar] 61.Matthews DR, Dejager S, Ahren B, et al
Retatrutide may become an important part of the future of peptide-based weight loss care
Tirzepatide is unique in the way that it works as it is made up of GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) which work in conjunction with one another to create weight loss
This is encouraging and has potential to be relevant when considering prescribing choices to lower ICP
At the time, Lilly said the doses were also "priced at a 50% or greater discount compared to the list price of all other incretin (GLP-1) medicines for obesity." GLP-1 agonists are a class of Type 2 diabetes drugs that improve blood sugar control but may also lead to weight loss
For large bowel obstruction caused by colonic tumours , especially left-sided tumours, endoscopic stenting can be considered